Pharmaceutical professional performance in the clinical analysis laboratory: attributions and challenges

Abstract

This work discusses the performance of the pharmaceutical professional in front of the clinical analysis laboratory, constituting an important link in the dialogue between pharmacist/applicants and patient. In this sense, the way in which this professional acts can influence the dynamics of the laboratory and the treatment of the patient. The objective was to seek scientific evidence on the performance of the pharmaceutical professional in a clinical analysis laboratory, with a view to dimensioning their attributions and challenges faced. The methodology used was exploratory and bibliographic with a qualitative approach, from July to September 2022, using the LILACS and Medline databases via PubMed. Fifteen articles were selected where it was observed that the pharmaceutical clinical analyst fulfills an extensive network of routine tasks distinguished in three main phases: pre-analytical, analytical and post-analytical. The pharmacist's attributions are based on the three axes of health care, technology and innovation in health and health management; as challenges faced are multiprofessionality, Hemotherapy and operational innovation to face the increasingly growing automations in the laboratory market, enabling reliable and safe report results, since they are fundamental for decision-making regarding the health of patients. In view of the above, it is necessary for the clinical analyst pharmacist to adapt to the new reality in his professional practice, especially in his academic training, given the need to focus on the health care of the population that integrates from curative, preventive to educational means either individually or as a member of a multidisciplinary team.